Form 4: Keros Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Lorena Raquel Lerner, Chief Scientific Officer of Keros Therapeutics, Inc., sold 3,568 shares of common stock on August 18, 2026 for $10.29 per share.
Summary
- Open-market sale: disposed of 3,568 Common Stock at $10.29 ($36,715) on August 18, 2026; holds 27,559 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $36,715 of stock on the open market.
Insider Transactions
Lorena Raquel Lerner — Officer (Chief Scientific Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-18 | Open-market sale | Common Stock | 3,568 | $10 | $36.7K | 27,559 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-18 | Open-market sale (3,568 shares) |
Keywords
insider transaction, Form 4, KROS, Keros Therapeutics, Inc., bearish, Lorena Raquel Lerner
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.